logo

Shariah compliance overview

Halal

Novo Nordisk A/S (NVO) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Novo Nordisk A/S

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint.

Novo Nordisk A/S (NVO) operates in the Healthcare sector, in the Drug Manufacturers - General industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.41% (limit 5%), interest-bearing debt is 4.86% (limit 30%) and interest-bearing securities and assets are 1.07% (limit 30%).

If you hold NVO, give 0.41% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
0.41%Limit 5%Pass
Interest-bearing debt
4.86%Limit 30%Pass
Interest-bearing securities and assets
1.07%Limit 30%Pass
Dividend purification
0.41%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Novo Nordisk A/S (NVO). Current Akinda screening label: Halal.